XML 72 R63.htm IDEA: XBRL DOCUMENT v3.23.2
Business Acquisition - Pro Forma Financial Information (Details) - Acacia Pharma - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Business Acquisition, Pro Forma Information, Nonrecurring Adjustment [Line Items]        
Business Acquisition, Pro Forma Revenue $ 64,646 $ 74,546 $ 130,951 $ 191,038
Business Acquisition, Pro Forma Net Income (Loss) $ 5,164 $ 2,875 $ 10,914 $ 36,124